Does Light Therapy Actually Work for Depression?

Light therapy does work for depression, and the evidence is stronger than many people expect. For seasonal depression (SAD), about 61% of people who use a bright light box every morning respond to treatment within four weeks. For non-seasonal depression, the numbers are also encouraging: roughly 41% of people achieve full remission with light therapy, compared to about 24% with placebo. It works through specific brain pathways, not just a vague mood boost, and clinical guidelines in Canada now list it as a first-line treatment for winter depression.

How Strong Is the Evidence?

The case for light therapy in seasonal depression has been building for decades. In a controlled trial published in JAMA Psychiatry that used sham devices as placebos, 61% of patients using morning light responded after four weeks, versus 32% on placebo. The benefit wasn’t instant. It took at least three weeks for a clear separation between light therapy and placebo to emerge, and the biggest advantage was in producing full remissions rather than partial improvement.

What surprised researchers more recently is how well light therapy performs for people whose depression has nothing to do with winter. A 2024 meta-analysis pooling 11 trials and 858 patients found that bright light therapy produced remission in 40.7% of participants, compared to 23.5% with control treatments. Response rates (meaning meaningful symptom reduction, not necessarily full remission) were even higher: 60.4% versus 38.6%. These trials used light therapy as an add-on to other treatments, suggesting it provides a real boost even when someone is already receiving standard care.

Light Therapy vs. Antidepressants

One of the more striking findings comes from a randomized trial that directly compared light therapy to fluoxetine (the active ingredient in Prozac) for non-seasonal major depression. Light therapy alone produced a larger improvement in depression scores than fluoxetine alone. In fact, light therapy was statistically superior to placebo in that trial, while fluoxetine on its own was not. The combination of both treatments together performed best of all, beating fluoxetine monotherapy by a significant margin.

This doesn’t mean light therapy replaces medication for everyone. But it does suggest that for some people, sitting in front of a bright light every morning can be at least as effective as taking an antidepressant, with far fewer systemic side effects.

Why Light Affects Your Mood

Light therapy isn’t just about “feeling sunny.” Bright light enters through your eyes and reaches specialized cells in the retina that connect directly to brain regions involved in mood regulation. One key pathway runs from the retina through a relay station in the brain to a structure called the lateral habenula, which acts as a gatekeeper between your emotional brain and the systems that produce serotonin and dopamine. Bright light activates inhibitory neurons along this pathway, essentially turning down the volume on a brain region that, when overactive, contributes to depressive behavior.

There’s also a circadian component. People with seasonal depression tend to have internal clocks that run late relative to the day-night cycle. Morning bright light pushes the clock earlier, advancing the timing of melatonin release and resynchronizing the body’s rhythms. Studies have confirmed this by showing that morning light shifts melatonin onset earlier in depressed patients but not in healthy controls, and that depleting the raw material for serotonin production reverses the antidepressant effect of light therapy. Both the circadian reset and the direct mood-regulating pathway appear to contribute.

Morning Timing Matters

Morning light is significantly more effective than evening light for treating depression. This was established in early controlled studies and has held up consistently. Morning exposure corrects the delayed circadian rhythms common in depression, while evening light can push them even later. In the JAMA trial on seasonal depression, 61% of morning light users responded compared to 50% of evening light users, a gap that was statistically significant at the three-week mark.

The practical recommendation from Yale’s depression research program is to complete your light session before 8 a.m., seven days a week. Consistency matters. Skipping days reduces the cumulative effect, and most people don’t see meaningful improvement until they’ve been at it for two to three weeks.

How to Use a Light Box

The standard protocol is 30 minutes per day at 10,000 lux. Lux measures how much light actually reaches your eyes, and it depends heavily on distance. Most commercial light boxes deliver 10,000 lux at somewhere between 12 and 24 inches, so the exact positioning varies by device. If you sit farther back, you need more time: 60 minutes at 5,000 lux or 120 minutes at 2,500 lux are considered roughly equivalent to 30 minutes at 10,000 lux.

You don’t stare directly at the light. The box should be positioned so the light projects slightly downward toward your face while you eat breakfast, read, or work. Your eyes stay open, but you look at whatever you’re doing, not at the light source itself. This setup minimizes glare while still delivering enough light to the retina.

When choosing a light box, look for a few things:

  • Intensity: At least 10,000 lux at the distance you’ll actually sit. Manufacturers list this, but the usable distance varies from about 11 inches for smaller units to 24 inches for larger ones.
  • UV filtration: Therapeutic light boxes should filter out ultraviolet light. You want bright white light, not the kind that causes sunburn.
  • Surface area: Larger light-emitting surfaces distribute illumination more evenly. This means you can shift your head a few inches without dropping below therapeutic intensity. Panels that maintain at least 5,000 lux when your head moves five inches in any direction are considered adequate.

Small, phone-sized devices and dawn simulators may have some benefit, but the bulk of clinical evidence comes from full-sized fluorescent or LED light boxes.

Side Effects and Safety Concerns

Light therapy is well tolerated by most people. The most common complaints are eyestrain and mild headache, both of which usually resolve by increasing the distance to the box slightly. These side effects are minor compared to those of most antidepressant medications.

There are a few situations where caution is warranted. People with retinal diseases like macular degeneration, or conditions like diabetes that can affect the retina, should avoid bright light therapy. Anyone over 65 should get an eye exam before starting. Certain medications, including some antibiotics and acne treatments, increase photosensitivity and could cause a rash or skin reaction during light exposure.

The most serious risk applies to people with bipolar disorder. Like all antidepressant treatments, light therapy can occasionally trigger a hypomanic or manic episode, a state of overactivation that can lead to impulsive or dangerous behavior. There are also rare reports of light therapy increasing agitation before mood improves, which in vulnerable individuals could worsen suicidal thinking. For people with bipolar disorder, light therapy should only be used under close clinical supervision.

What to Realistically Expect

Light therapy is not a magic fix, but the data consistently shows it performs as well as, and sometimes better than, first-line antidepressant medications for both seasonal and non-seasonal depression. You should expect to commit to daily morning sessions for at least three weeks before judging whether it’s working. Most people who respond notice gradual shifts in energy, sleep quality, and mood rather than a sudden change.

For seasonal depression, light therapy is considered a first-line standalone treatment. For non-seasonal depression, the strongest evidence supports using it alongside other treatments, whether that’s medication, therapy, or both. The combination of light therapy and an antidepressant outperformed either one alone in head-to-head testing, making it a useful tool to layer into an existing treatment plan.